세계의 개발 및 제조 수탁 기관(CDMO) 아웃소싱 시장 규모는 2023년 2,286억 3,000만 달러로 평가되었고, 2024년 2,432억 6,000만 달러에서 2032년에는 3,995억 8,000만 달러로 성장할 전망이며, 예측기간 2025년부터 2032년까지의 CAGR은 6.4%로 성장할 전망입니다.
세계의 개발 및 제조 수탁 기관(CDMO) 아웃소싱 시장은 혁신적인 치료에 대한 수요 증가와 신약의 복잡화에 의해 큰 성장을 이루고 있습니다. 제약 기업은 크고 작은 의약품 개발 프로세스를 합리화하기 위해 CDMO와 전략적으로 제휴하여 전문적인 사내 시설을 불필요하게 하고 있습니다. CDMO는, 의약품 연구나 전임상 검사로부터 원약(API)이나 최종 제품의 제조까지, 밸류 체인 전체를 망라하는 포괄적인 서비스를 제공하고 있습니다. 많은 소규모 제약기업들이 사내에 제조능력을 갖지 못하기 때문에 이 동향은 가속화될 것으로 예상됩니다. 그 결과, 효율적이고 시의적절한 의약품 개발과 상업화를 실현하기 위해서 CDMO와의 파트너십은 더욱더 불가결한 것이 될 것으로 생각됩니다.
Global Contract Development And Manufacturing Organization (CDMO) Outsourcing Market size was valued at USD 228.63 billion in 2023 and is poised to grow from USD 243.26 billion in 2024 to USD 399.58 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).
The global contract development and manufacturing organization (CDMO) market is experiencing significant growth, driven by the rising demand for innovative therapeutics and the increasing complexity of new medicines. Pharmaceutical companies, both large and small, are strategically partnering with CDMOs to streamline their drug development processes, eliminating the need for specialized in-house facilities. CDMOs offer a comprehensive range of services that encompass the entire value chain, from drug research and preclinical trials to manufacturing active pharmaceutical ingredients (API) and finished products. This trend is expected to accelerate as many small pharmaceutical firms lack internal manufacturing capabilities. As a result, CDMO partnerships are set to become increasingly vital in ensuring efficient and timely drug development and commercialization.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contract Development And Manufacturing Organization (Cdmo) Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Contract Development And Manufacturing Organization (Cdmo) Outsourcing Market Segmental Analysis
Global Contract Development And Manufacturing Organization (CDMO) Outsourcing Market is segmented by CMO, CRO and region. Based on CMO, the market is segmented into API Manufacturing, Finished Product Manufacturing, Packaging and Others. Based on CRO, the market is segmented into Early Phase Development Services, Clinical, Laboratory Service and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Contract Development And Manufacturing Organization (Cdmo) Outsourcing Market
The global Contract Development and Manufacturing Organization (CDMO) outsourcing market is driven by the increased prevalence of chronic diseases driven by factors such as a growing westernized lifestyle, economic growth, and rising populations. Over 133 million Americans are affected by chronic conditions, representing over 40% of the population, and projections indicate that worldwide figures may reach 157 million by 2020. The market is further bolstered by significant investments from CDMOs looking to innovate and expand geographically, as seen in AbbVie's new API facility in Singapore. Additionally, partnerships between emerging companies like Cugene Inc. and established firms are facilitating market growth, particularly in innovative treatments for autoimmune and inflammatory diseases.
Restraints in the Global Contract Development And Manufacturing Organization (Cdmo) Outsourcing Market
The growth of the Global Contract Development and Manufacturing Organization (CDMO) outsourcing market is likely to be hindered by several key factors. Stringent government regulations and a decrease in the approval rates for various small molecules and biologics in developed regions play a significant role in this restraint. Furthermore, smaller-scale CDMOs that lack advanced equipment are at a higher risk of encountering process errors, compromising quality, and experiencing escalating costs. These issues collectively pose challenges that may adversely impact the overall expansion of the CDMO market during the forecast period, complicating operations and reducing competitiveness.
Market Trends of the Global Contract Development And Manufacturing Organization (Cdmo) Outsourcing Market
The global Contract Development and Manufacturing Organization (CDMO) outsourcing market is witnessing significant fragmentation driven by the rising demand for rapid innovations and efficient process solutions in drug development. As pharmaceutical companies seek to streamline operations and enhance productivity, CDMOs are increasingly partnering with both small and large pharmaceutical and biotech enterprises, as well as life sciences corporations. This trend not only bolsters their service offerings but also fosters collaboration and knowledge-sharing, ultimately leading to improved operational efficiencies and accelerated time-to-market for new therapeutics. This dynamic environment is characterized by strategic alliances, technological advancements, and a focus on customized solutions to meet diverse client needs.